Fortieth Annual Meeting of the Society for Leukocyte Biology

点击翻译按钮获取中文摘要

Project Summary: Conference Plan 40th Annual Meeting of the Society for Leukocyte Biology: ?Inflammation, Innate Immunity, and Cancer? Organizers: Barrett J. Rollins, MD, PhD, Dana-Farber Cancer Inst., Harvard Med. Sch. Frances Balkwill, PhD, Inst. of Cancer and the Cancer Res.-UK Clinical Ctr. Location: The Royal Sonesta Hotel, Cambridge, Massachusetts Dates: October 11-13, 2007 Specific Aims: Recent advances indicate that inflammatory and innate immune responses have profound effects on cancer. A substantial number of scientists working on fundamental aspects of inflammation or innate immunity have not had an opportunity to consider how their findings might be relevant to problems in cancer biology. The main goals of the meeting are: 1) to provide a format that encourages interactions between scientists working on diverse aspects of phagocytes and cancer biology; and 2) to highlight the best and most innovative work on the mechanisms that underlie the biology of inflammation, innate immunity and cancer. Specific Aim 1. To provide a forum for 300-400 participants from academic, governmental, and industrial laboratories and hospitals to share recent advances in inflammation and innate immunity and their effects on cancer. Presentations will include talks by invited speakers as well as talks and poster presentations chosen from submitted abstracts. Specific Aim 2. To present a program that captures the most significant advances from the previous year in the following areas including: innate leukocyte function in host defense; mechanisms of innate immune recognition of pathogens and toxins; the mechanisms governing cytokine control of leukocyte function; mechanisms whereby the inflammatory and innate immune responses affect cancer development and progression; therapeutic intervention in inflammation and innate immune responses and their potential effect on cancer. Specific Aim 3. To provide an opportunity for young investigators (graduate students, postdoctoral fellows, and junior faculty) to interact closely with well-established and influential scientists in their fields, to present their research, and to recognize outstanding research by providing an opportunity for oral presentations. Specific Aim 4. To provide an opportunity for academic and government scientists, as well as scientists-intraining, to interact with their counterparts in commercial drug development. Specific Aim 5. To provide opportunities for women, underrepresented minorities, and persons with disabilities to participate in a meeting that showcases their results and facilitates interactions with other scientists in their fields.